Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Type 2 (February 10, 2010)

Report a Concern
Starting date:
February 10, 2010
Posting date:
March 15, 2010
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2010A69

Reason

Based on new information, complete directions for use including risk statements are required on the labels of some products containing 40 mg/dosage unit or more of glucomannan to mitigate throat, esophageal or intestinal obstruction following ingestion of these products.

Depth of distribution

Distributed to health food stores across Canada

Affected products

Type 2

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Capsules

Strength

  • 635 mg/capsule (containing 250 mg of Glucomannan)

Lot or serial number

3694 2886

Companies

Recalling Firm
Biomed International Products Corp.
Unit 102-3738 North Fraser Way
Burnaby British Columbia
Canada V5J 5G7
Marketing Authorization Holder
Biomed International Products Corp.
Unit 102-3738 North Fraser Way
Burnaby British Columbia
Canada V5J 5G7